Fibrinogen deficiency is compatible with the development of atherosclerosis in mice

被引:73
作者
Xiao, Q
Danton, MJS
Witte, DP
Kowala, MC
Valentine, MT
Degen, JL
机构
[1] Childrens Hosp, Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA
[2] Childrens Hosp, Res Fdn, Div Pathol, Cincinnati, OH 45229 USA
[3] Bristol Myers Squibb Co, Div Cardiovasc Drug Discovery, Princeton, NJ 08543 USA
关键词
atherosclerosis; fibrinogen; fibrin degradation products; apolipoprotein E;
D O I
10.1172/JCI1461
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A critical role of the coagulation system in the development of atherosclerosis has been frequently postulated based on a variety of indirect observations, including the expression of procoagulants and fibrinolytic factors within atherosclerotic vessels, the presence of substantial amounts of fibrin(ogen) and fibrin degradation products within intimal lesions, the cellular infiltration and assimilation of mural thrombi Into developing plaques, and the identification of high plasma fibrinogen (Fib) levels as an independent risk factor for the development of ischemic heart disease, To directly examine the role of fibrin(ogen) in atherogenesis, Fib-deficient mice were crossed to atherosclerosis-prone apolipoprotein E (apo E)-deficient mice. Both apo E-/- and apo E-/-/Fib(-/-) mice developed lesions throughout the entire aortic tree, ranging in appearance from simple fatty streaks to complex fibrous plaques, Furthermore, remarkably little difference in lesion size and complexity was observed within the aortae of age- and gender-matched apo E-/- and apo E-/-/Fib(-/-) mice. These results indicate that the contribution of fibrin(ogen) to intimal mass and focal cell adhesion, migration, and proliferation is not strictly required for the development of advanced atherosclerotic disease in mice with a severe defect in lipid metabolism.
引用
收藏
页码:1184 / 1194
页数:11
相关论文
共 47 条
[1]   IDENTIFICATION AND DISTRIBUTION OF FIBRINOGEN, FIBRIN, AND FIBRIN(OGEN) DEGRADATION PRODUCTS IN ATHEROSCLEROSIS - USE OF MONOCLONAL-ANTIBODIES [J].
BINI, A ;
FENOGLIO, JJ ;
MESATEJADA, R ;
KUDRYK, B ;
KAPLAN, KL .
ARTERIOSCLEROSIS, 1989, 9 (01) :109-121
[2]  
BINI A, 1995, ANN NY ACAD SCI, V748, P461
[3]   Mouse models of atherosclerosis [J].
Breslow, JL .
SCIENCE, 1996, 272 (5262) :685-688
[4]   PLASMINOGEN DEFICIENCY CAUSES SEVERE THROMBOSIS BUT IS COMPATIBLE WITH DEVELOPMENT AND REPRODUCTION [J].
BUGGE, TH ;
FLICK, MJ ;
DAUGHERTY, CC ;
DEGEN, JL .
GENES & DEVELOPMENT, 1995, 9 (07) :794-807
[5]   Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency [J].
Bugge, TH ;
Kombrinck, KW ;
Flick, MJ ;
Daugherty, CC ;
Danton, MJS ;
Degen, JL .
CELL, 1996, 87 (04) :709-719
[6]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[7]   Impaired arterial neointima formation in mice with disruption of the plasminogen gene [J].
Carmeliet, P ;
Moons, L ;
Ploplis, V ;
Plow, E ;
Collen, D .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :200-208
[8]  
CHIESA G, 1992, J BIOL CHEM, V267, P24369
[9]   FIBRINOGEN AS A CARDIOVASCULAR RISK FACTOR - A METAANALYSIS AND REVIEW OF THE LITERATURE [J].
ERNST, E ;
RESCH, KL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) :956-963
[10]   ROLE OF THROMBOSIS IN ATHEROSCLEROSIS AND ITS COMPLICATIONS [J].
FALK, E ;
FERNANDEZORTIZ, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (06) :B5-B11